Cao Z, Bell JB, Mohanty JG, Nagababu E, Rifkind JM. Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the vasculature: a new mechanism for nitrite-induced vasodilation. Am J Physiol Heart Circ Physiol 297: H1494 -H1503, 2009. First published August 21, 2009 doi:10.1152/ajpheart.01233.2008.-A role for nitric oxide (NO) produced during the reduction of nitrite by deoxygenated red blood cells (RBCs) in regulating vascular dilation has been proposed. It has not, however, been satisfactorily explained how this NO is released from the RBC without first reacting with the large pools of oxyhemoglobin and deoxyhemoglobin in the cell. In this study, we have delineated a mechanism for nitrite-induced RBC vasodilation that does not require that NO be released from the cell. Instead, we show that nitrite enhances the ATP release from RBCs, which is known to produce vasodilation by several different methods including the interaction with purinergic receptors on the endothelium that stimulate the synthesis of NO by endothelial NO synthase. This mechanism was established in vivo by measuring the decrease in blood pressure when injecting nitrite-reacted RBCs into rats. The observed decrease in blood pressure was not observed if endothelial NO synthase was inhibited by N -nitro-L-arginine methyl ester (L-NAME) or when any released ATP was degraded by apyrase. The nitrite-enhanced ATP release was shown to involve an increased binding of nitrite-modified hemoglobin to the RBC membrane that displaces glycolytic enzymes from the membrane, resulting in the formation of a pool of ATP that is released from the RBC. These results thus provide a new mechanism to explain nitrite-induced vasodilation. nitrite reduction; nitric oxide; anerobic glycolysis; hypoxia; red blood cell; adenosine 5Ј-triphosphate NITRIC OXIDE (NO) as a vasodilator plays a major role in regulating blood flow and vascular tone (19,20). A role for red blood cell (RBC) deoxygenation in the delivery of NO has been proposed (22). RBC-delivered NO has been considered as contributing to normal physiological hypoxic vasodilatation (43), as well as a source for the additional NO required under various pathological conditions (12,18,24,40). It, however, needs to be explained how the RBC increases the availability of NO. Two pathways have been proposed for RBC-induced NO-associated vasodilation under hypoxic conditions: 1) the release of some of the adenosine 5Ј-triphosphate (ATP) from RBCs under hypoxic conditions (10, 49) and 2) the interaction of this ATP with purinergic receptors (4) stimulate the synthesis of NO by endothelial NO synthase (eNOS) (2, 10, 49). The direct release of NO from RBCs under hypoxic conditions (8,22,26,33,42) has a vasodilatory effect. The source of the RBC-derived NO has been extensively studied. RBCs have been reported to have NO synthase activity (26), although the role of this enzyme has not been established. The original hypothesis for the accumulation of RBC NO (22) involved NO released from the endothelium being taken up...